Liver Cancer - Genesis, Progression and Metastasis - Couverture rigide

9781803564135: Liver Cancer - Genesis, Progression and Metastasis

Couverture rigide

ISBN 10 : 180356413X ISBN 13 : 9781803564135

Editeur : IntechOpen, 2023

Afficher les exemplaires de cette �dition comportant l'ISBN

Hepatocellular carcinoma (HCC) is a common tumor type arising from several distinct etiologies. It is usually diagnosed late and is difficult to treat. This volume presents an overview of selected aspects of HCC pathogenesis, and research aimed at developing diagnostic biomarkers. It points to a number of putative therapeutic targets, including signal transduction pathways, metabolic and epigenetic alterations in tumor cells, the tumor microenvironment, the gut microbiome, and functions of immune effector cells. Given the multi-step nature of most cancers, including HCC, future drug development will most likely require combination therapies that will simultaneously target multiple steps in hepatocarcinogenesis.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: IntechOpen
Date d'�dition: 2023
Langue: anglais
ISBN 10: 180356413X
ISBN 13: 9781803564135
Reliure: Reli�
Nombre de pages: 146
�diteur: Feitelson Mark, Arzumanyan Alla
Coordonn�es du fabricant: non disponible
Personne responsable: non disponible

R�sultats de recherche pour Liver Cancer - Genesis, Progression and Metastasis

Image fournie par le vendeur

Liver Cancer : Genesis, Progression and Metastasis

Mark Feitelson

Edit� par Intechopen, 2023

ISBN 10 : 180356413X ISBN 13 : 9781803564135

Neuf Couverture rigide

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Hepatocellular carcinoma (HCC) is a common tumor type arising from several distinct etiologies. It is usually diagnosed late and is difficult to treat. This volume presents an overview of selected aspects of HCC pathogenesis, and research aimed at developing diagnostic biomarkers. It points to a number of putative therapeutic targets, including signal transduction pathways, metabolic and epigenetic alterations in tumor cells, the tumor microenvironment, the gut microbiome, and functions of immune effector cells. Given the multi-step nature of most cancers, including HCC, future drug development will most likely require combination therapies that will simultaneously target multiple steps in hepatocarcinogenesis. N� de r�f. du vendeur 9781803564135

Contacter le vendeur